Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

View the 50 largest pharmaceutical companies in the world listings here

Catalent in the Drug Discovery & Development Pharma 50

Catalent

Rank: 45

2021 Rank: 44

Somerset, New Jersey, United States
www.catalent.com

2021 Revenues ($USD) : $3,998,000,000
2021 R&D spend : $21,000,000
2021 Number of Employees : 17,300
Fiscal Year End : 6/30/2021
Leader : CEO John Chiminski

The Somerset, N.J.–based contract development and manufacturing organization (CDMO) focuses on drug delivery, biologics, drug manufacturing and gene therapies. In 2021, the company helped produce more than 1 billion COVID-19 vaccine doses. Also in 2021, the company acquired Bettera Wellness, a gummies manufacturer, to expand into the nutraceuticals market. Catalent’s biologics division had a 66% annual growth rate. After entering the cell therapy market in February 2020, the company worked in 2021 to expand its infrastructure. Catalent joined the S&P 500 index on September 21, 2020. —BB

Catalent

[Image courtesy of Catalent]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50